These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 10210704

  • 1. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.
    Mosterd A, D'Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, Levy D.
    N Engl J Med; 1999 Apr 22; 340(16):1221-7. PubMed ID: 10210704
    [Abstract] [Full Text] [Related]

  • 2. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K, Gerdts E, Aurigemma GP, Boman K, Dahlöf B, Nieminen MS, Olsen MH, Okin PM, Palmieri V, Rokkedal JE, Devereux RB.
    Blood Press; 2010 Jun 22; 19(3):169-75. PubMed ID: 20438307
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E, Muiesan ML.
    J Hypertens Suppl; 2002 May 22; 20(2):S34-8. PubMed ID: 12183849
    [Abstract] [Full Text] [Related]

  • 4. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K, Okin PM, Olsen MH, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Nieminen MS, Thygesen K.
    Circulation; 2007 Aug 14; 116(7):700-5. PubMed ID: 17664372
    [Abstract] [Full Text] [Related]

  • 5. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM.
    J Electrocardiol; 2009 Aug 14; 42(6):584-8. PubMed ID: 19631946
    [Abstract] [Full Text] [Related]

  • 6. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J, Cea-Calvo L, Lozano JV, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J, ERIC-HTA 2003 Study Investigators.
    J Hypertens; 2006 Apr 14; 24(4):663-9. PubMed ID: 16531794
    [Abstract] [Full Text] [Related]

  • 7. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
    Olsen MH, Wachtell K, Ibsen H, Lindholm LH, Dahlöf B, Devereux RB, Kjeldsen SE, Oikarinen L, Okin PM, LIFE Study Investigators.
    J Hypertens; 2006 Apr 14; 24(4):775-81. PubMed ID: 16531808
    [Abstract] [Full Text] [Related]

  • 8. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
    Ibsen H, Pedersen OL, Dahlöf B, Kjeldsen SE, Lindholm LH.
    Ugeskr Laeger; 2003 Jan 27; 165(5):456-9. PubMed ID: 12599843
    [Abstract] [Full Text] [Related]

  • 9. Ventricular arrhythmias in hypertension: in which patients do they occur?
    Mayet J, Shahi M, Poulter NR, Sever PS, Thom SA, Foale RA.
    J Hypertens; 1995 Feb 27; 13(2):269-76. PubMed ID: 7615959
    [Abstract] [Full Text] [Related]

  • 10. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M, Boffano GM, Procopio M, Reynaud S, Allemano P, Rizzi G.
    G Ital Cardiol; 1998 Jan 27; 28(1):38-44. PubMed ID: 9493044
    [Abstract] [Full Text] [Related]

  • 11. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J.
    Rev Esp Cardiol; 2006 Feb 27; 59(2):136-42. PubMed ID: 16540035
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B.
    Curr Med Res Opin; 2007 Feb 27; 23(2):259-70. PubMed ID: 17288679
    [Abstract] [Full Text] [Related]

  • 14. Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population.
    Shipilova T, Pshenichnikov I, Kaik J, Volozh O, Abina J, Kalev M, Lass J, Karai D.
    Blood Press; 2003 Feb 27; 12(1):12-8. PubMed ID: 12699130
    [Abstract] [Full Text] [Related]

  • 15. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.
    Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP.
    N Engl J Med; 1990 May 31; 322(22):1561-6. PubMed ID: 2139921
    [Abstract] [Full Text] [Related]

  • 16. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R, Solorio S, Vargas-Salado E, Aguirre-Vázquez C, Hernández-González MA, Olvera-Lopez JA, Rodríguez-Mariscal L, Luna-Ruiz MA, Guillén Contreras JM, Murillo Ortiz BO.
    Arch Cardiol Mex; 2008 May 31; 78(4):392-9. PubMed ID: 19205547
    [Abstract] [Full Text] [Related]

  • 17. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group.
    Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G.
    CMAJ; 1992 Jun 01; 146(11):1997-2005. PubMed ID: 1596849
    [Abstract] [Full Text] [Related]

  • 18. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D, Rumboldt Z, Bagatin J, Polić S.
    Croat Med J; 2002 Dec 01; 43(6):672-9. PubMed ID: 12476475
    [Abstract] [Full Text] [Related]

  • 19. Left ventricular hypertrophy in hypertension.
    Dunn FG, Pfeffer MA.
    N Engl J Med; 1999 Apr 22; 340(16):1279-80. PubMed ID: 10210713
    [No Abstract] [Full Text] [Related]

  • 20. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.
    Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, Mureddu G, Pede S, Maggioni AP, Lucci D, Reboldi G, Cardio-Sis investigators.
    Lancet; 2009 Aug 15; 374(9689):525-33. PubMed ID: 19683638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.